Sid Selva‐Nayagam

726 total citations
9 papers, 580 citations indexed

About

Sid Selva‐Nayagam is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, Sid Selva‐Nayagam has authored 9 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Sid Selva‐Nayagam's work include Burkholderia infections and melioidosis (2 papers), Amoebic Infections and Treatments (2 papers) and Colorectal Cancer Screening and Detection (2 papers). Sid Selva‐Nayagam is often cited by papers focused on Burkholderia infections and melioidosis (2 papers), Amoebic Infections and Treatments (2 papers) and Colorectal Cancer Screening and Detection (2 papers). Sid Selva‐Nayagam collaborates with scholars based in Australia and United Kingdom. Sid Selva‐Nayagam's co-authors include Bart J. Currie, Paul Snelling, Vicki Krause, Nicholas M. Anstey, Dale Fisher, Sarah Huffam, David F. Lo, Gary D. Lum, Dianne Stephens and Diane Howard and has published in prestigious journals such as Clinical Infectious Diseases, BMJ Open and BMC Cancer.

In The Last Decade

Sid Selva‐Nayagam

8 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sid Selva‐Nayagam Australia 7 431 105 90 56 49 9 580
Arturo Montineri Italy 10 275 0.6× 44 0.4× 23 0.3× 46 0.8× 85 1.7× 24 450
N. Kristine Leos United States 11 189 0.4× 15 0.1× 17 0.2× 50 0.9× 89 1.8× 18 473
Lucy Bell United Kingdom 12 233 0.5× 15 0.1× 45 0.5× 160 2.9× 345 7.0× 18 601
Julie M. Bryar United States 7 436 1.0× 7 0.1× 111 1.2× 18 0.3× 400 8.2× 9 544
Silke Grumaz Germany 7 297 0.7× 24 0.2× 54 0.6× 33 0.6× 107 2.2× 13 497
Alireza Janbakhsh Iran 12 175 0.4× 4 0.0× 40 0.4× 40 0.7× 98 2.0× 49 400
Kathleen A. Linder United States 11 257 0.6× 4 0.0× 38 0.4× 18 0.3× 199 4.1× 31 336
Linglin Zhang China 11 110 0.3× 32 0.3× 17 0.2× 16 0.3× 73 1.5× 24 317
Sarah Doffman United Kingdom 10 225 0.5× 9 0.1× 38 0.4× 79 1.4× 204 4.2× 15 598
Julie M. Steinbrink United States 10 208 0.5× 5 0.0× 20 0.2× 43 0.8× 177 3.6× 28 405

Countries citing papers authored by Sid Selva‐Nayagam

Since Specialization
Citations

This map shows the geographic impact of Sid Selva‐Nayagam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sid Selva‐Nayagam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sid Selva‐Nayagam more than expected).

Fields of papers citing papers by Sid Selva‐Nayagam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sid Selva‐Nayagam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sid Selva‐Nayagam. The network helps show where Sid Selva‐Nayagam may publish in the future.

Co-authorship network of co-authors of Sid Selva‐Nayagam

This figure shows the co-authorship network connecting the top 25 collaborators of Sid Selva‐Nayagam. A scholar is included among the top collaborators of Sid Selva‐Nayagam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sid Selva‐Nayagam. Sid Selva‐Nayagam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Roder, David, Margaret Davy, Sid Selva‐Nayagam, et al.. (2019). Exploring the added value of hospital-registry data for showing local service outcomes: cancers of the ovary, fallopian tube and peritoneum. BMJ Open. 9(2). e024036–e024036.
2.
Roder, David, Margaret Davy, Sid Selva‐Nayagam, et al.. (2018). Using hospital registries in Australia to extend data availability on vulval cancer treatment and survival. BMC Cancer. 18(1). 858–858. 3 indexed citations
3.
Singhal, Nimit, Anna Rachelle Mislang, Rajiv Kumar, et al.. (2017). Phase II study of celecoxib with docetaxel chemoradiotherapy followed by consolidation chemotherapy docetaxel plus cisplatin with maintenance celecoxib in inoperable stage III nonsmall cell lung cancer. Asia-Pacific Journal of Clinical Oncology. 14(1). 91–100. 9 indexed citations
4.
George, Mathew, et al.. (2010). Late solitary testicular metastasis from rectal cancer. Journal of Cancer Research and Therapeutics. 6(1). 89–89. 6 indexed citations
5.
Goldstein, David, M. Corona Gainford, Chris Brown, et al.. (2010). Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas. Cancer Chemotherapy and Pharmacology. 67(3). 519–525. 10 indexed citations
6.
Condon, John R., Tony Barnes, Bruce K. Armstrong, Sid Selva‐Nayagam, & Mark Elwood. (2005). Stage at diagnosis and cancer survival for Indigenous Australians in the Northern Territory. The Medical Journal of Australia. 182(6). 277–280. 93 indexed citations
7.
Currie, Bart J., Dale Fisher, Sarah Huffam, et al.. (2003). Prevention of opportunistic infections in immunosuppressed patients in the tropical Top End of the Northern Territory of Australia. Communicable Diseases Intelligence. 27. 526–532. 11 indexed citations
8.
Davis, Joshua S., Bart J. Currie, Dale Fisher, et al.. (2003). Prevention of opportunistic infections in immunosuppressed patients in the tropical top end of the Northern Territory.. PubMed. 27(4). 526–32. 33 indexed citations
9.
Currie, Bart J., Dale Fisher, Diane Howard, et al.. (2000). Endemic Melioidosis in Tropical Northern Australia: A 10‐Year Prospective Study and Review of the Literature. Clinical Infectious Diseases. 31(4). 981–986. 415 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026